Calabrese Salvatore 4
4 · Gain Therapeutics, Inc. · Filed May 19, 2022
Insider Transaction Report
Form 4
Calabrese Salvatore
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-05-19$8100.00/sh+3,000$24,300,000
4 · Gain Therapeutics, Inc. · Filed May 19, 2022
Common Stock